Invega (paliperidone) is being promoted as a new atypical antipsychotic for schizophrenia

Invega (paliperidone) is being promoted as a new atypical antipsychotic for schizophrenia.

But the ingredient in Invega is not really new...it's the active metabolite of risperidone (Risperdal).

Expect Invega to work as well as risperidone, and have similar side effects such as restlessness or extrapyramidal symptoms.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote